This country profile provides an overview of Gambia’s progress in reaching those in need of mass NTD treatment based on 2019 data.
*This includes all countries in Africa that are endemic for at least one of the five NTDs
Gambia does not require mass treatment for elephantiasis.
Gambia claims to have eliminated blinding trachoma as a public health problem.
Treatment coverage decreased from 48% in 2018 to 47% in 2019.
Treatment coverage decreased from 61% in 2018 to 0% in 2019.
Gambia does not require mass treatment for river blindness.
The ESPEN portal (a World Health Organization AFRO region project) provides maps and district-level data for the preventive chemotherapy diseases in the Gambia.